Oncology prices in China (2026)
China's top cancer centers run multidisciplinary clinics where imaging, pathology and a treatment plan are reviewed together — and domestically manufactured generics make many targeted and chemotherapy drugs far cheaper than in the US or Europe (based on public reports).
The first step is always a records review: your imaging, pathology and treatment history are read by a specialist who confirms what China can add. IMedCompanion collects your files, arranges the review, and only then books the in-person visit.
The national three-tier structure: public outpatient $3–7, international departments $55–130, private international hospitals $140–285.
Based on public reports; varies with regimen, drug originator vs domestic generic, and dose.
Range based on published information; quoted per hospital and often part of a staging package.
Drug prices differ sharply between originator products and domestically manufactured generics of the same molecule; your written quote lists the drug, origin and price for every cycle before you commit. Surgery and radiotherapy are quoted per case.
Prices are shown in approximate US dollars, converted at 1 USD = 7 RMB. Hospitals bill in RMB; your written quote from IMedCompanion shows both currencies before you commit.